Acumen Pharmaceuticals, Inc.
ABOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$102 | -$52 | -$43 | -$101 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10 | $6 | $3 | $1 |
| Change in WC | $12 | $4 | $4 | $0 |
| Other Non-Cash | -$5 | -$1 | $0 | $81 |
| Operating Cash Flow | -$86 | -$43 | -$35 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$171 | -$251 | -$42 | -$104 |
| Inv. Sales/Matur. | $219 | $79 | $81 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $48 | -$172 | $39 | -$104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $30 | $0 | $0 |
| Stock Issued | $8 | $122 | $4 | $169 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $0 | $32 |
| Financing Cash Flow | $7 | $152 | $4 | $200 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$31 | -$63 | $8 | $78 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $67 | $130 | $122 | $44 |
| End Cash | $36 | $67 | $130 | $122 |
| Free Cash Flow | -$86 | -$43 | -$35 | -$18 |